• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

联合评估腹部肥胖与非传统血脂参数对心血管代谢多重疾病的一级预防:来自中国健康与养老追踪调查(2011 - 2018年)的见解

Joint assessment of abdominal obesity and non-traditional lipid parameters for primary prevention of cardiometabolic multimorbidity: insights from the China health and retirement longitudinal study 2011-2018.

作者信息

Lai Hurong, Tu Yansong, Liao Caifeng, Zhang Shan, He Ling, Li Jian

机构信息

The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.

Faculty of Science, University of Melbourne, Grattan Street, Parkville, VIC, 3010, Australia.

出版信息

Cardiovasc Diabetol. 2025 Mar 8;24(1):109. doi: 10.1186/s12933-025-02667-y.

DOI:10.1186/s12933-025-02667-y
PMID:40057762
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11890515/
Abstract

BACKGROUND

Obesity and abnormal lipid metabolism increase the risk of various cardiometabolic diseases, including diabetes, heart disease, and stroke. However, the impact of abdominal obesity (AO) and non-traditional lipid parameters on the risk of cardiometabolic multimorbidity (CMM) remains unclear. This study aims to investigate the separate and combined effects of AO and non-traditional lipid parameters on the incidence risk of CMM.

METHODS

This study enrolled 7,597 eligible participants from the China health and retirement longitudinal study (CHARLS). Cox proportional hazards models were used to perform adjusted regression analyses and mediation analyses, with Kaplan-Meier analysis used for cumulative hazards. Restricted cubic splines were utilized to evaluate the nonlinear relationship between non-traditional lipid parameters and the risk of CMM among participants with AO. Subgroup analyses were conducted with stratification by age, gender, BMI, smoking status, drinking status, and hypertension to investigate interaction effects across different populations. Additionally, sensitivity analyses were further performed to evaluate the impact of various subgroups on diabetes, heart disease, and stroke.

RESULTS

During the 7-year follow-up period, a total of 699 participants (9.20%) were newly diagnosed with CMM. Kaplan-Meier curves revealed that the subgroup with both AO and high levels of non-traditional lipid parameters had the highest cumulative hazard for developing CMM. In the fully adjusted model, Cox regression analysis revealed that participants with both high levels of non-traditional lipid parameters and AO exhibited the highest risk of developing CMM. Subgroup and sensitivity analyses further confirmed the robustness of these findings, showing consistent results across different demographic groups and under various analytical conditions. Furthermore, AO was found to significantly mediated the associations between non-traditional lipid parameters and the risk of developing CMM.

CONCLUSION

The separate and combined effects of AO and non-traditional lipid parameters were significantly associated with the risk of developing CMM. Notably, AO may induce CMM by partially mediating the effects of serum lipids in human metabolism. The findings highlighted the importance of joint evaluation of AO and non-traditional lipid parameters for primary prevention of CMM.

摘要

背景

肥胖和脂质代谢异常会增加患各种心脏代谢疾病的风险,包括糖尿病、心脏病和中风。然而,腹部肥胖(AO)和非传统脂质参数对心脏代谢多发病(CMM)风险的影响仍不清楚。本研究旨在探讨AO和非传统脂质参数对CMM发病风险的单独及联合作用。

方法

本研究纳入了来自中国健康与养老追踪调查(CHARLS)的7597名符合条件的参与者。采用Cox比例风险模型进行调整后的回归分析和中介分析,采用Kaplan-Meier分析计算累积风险。利用受限立方样条评估AO参与者中非传统脂质参数与CMM风险之间的非线性关系。通过按年龄、性别、体重指数、吸烟状况、饮酒状况和高血压进行分层的亚组分析,研究不同人群中的交互作用。此外,进一步进行敏感性分析,以评估各亚组对糖尿病、心脏病和中风的影响。

结果

在7年的随访期内,共有699名参与者(9.20%)被新诊断为CMM。Kaplan-Meier曲线显示兼具AO和高水平非传统脂质参数的亚组发生CMM的累积风险最高。在完全调整模型中,Cox回归分析显示,非传统脂质参数水平高且有AO的参与者发生CMM的风险最高。亚组和敏感性分析进一步证实了这些发现的稳健性,在不同人口统计学组和各种分析条件下均显示出一致的结果。此外,发现AO显著介导了非传统脂质参数与发生CMM风险之间的关联。

结论

AO和非传统脂质参数的单独及联合作用均与发生CMM的风险显著相关。值得注意的是,AO可能通过部分介导血清脂质在人体代谢中的作用来诱发CMM。这些发现凸显了联合评估AO和非传统脂质参数对CMM一级预防的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b040/11890515/680f41d26278/12933_2025_2667_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b040/11890515/d5b6ca332727/12933_2025_2667_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b040/11890515/d8626fc21426/12933_2025_2667_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b040/11890515/e69d364aa37c/12933_2025_2667_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b040/11890515/87463217cb8b/12933_2025_2667_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b040/11890515/680f41d26278/12933_2025_2667_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b040/11890515/d5b6ca332727/12933_2025_2667_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b040/11890515/d8626fc21426/12933_2025_2667_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b040/11890515/e69d364aa37c/12933_2025_2667_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b040/11890515/87463217cb8b/12933_2025_2667_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b040/11890515/680f41d26278/12933_2025_2667_Fig5_HTML.jpg

相似文献

1
Joint assessment of abdominal obesity and non-traditional lipid parameters for primary prevention of cardiometabolic multimorbidity: insights from the China health and retirement longitudinal study 2011-2018.联合评估腹部肥胖与非传统血脂参数对心血管代谢多重疾病的一级预防:来自中国健康与养老追踪调查(2011 - 2018年)的见解
Cardiovasc Diabetol. 2025 Mar 8;24(1):109. doi: 10.1186/s12933-025-02667-y.
2
[Associations between 4 lipid biomarkers and cardiometabolic multimorbidity development in middle aged and old adults in China].[中国中老年人群中4种脂质生物标志物与心血管代谢多种疾病发生之间的关联]
Zhonghua Liu Xing Bing Xue Za Zhi. 2024 Jul 10;45(7):923-931. doi: 10.3760/cma.j.cn112338-20231123-00314.
3
Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and cardiometabolic multimorbidity among middle-aged and older adults in China.中国中老年人群中非高密度脂蛋白胆固醇与高密度脂蛋白胆固醇比值与心血管代谢多重疾病的关联
BMC Public Health. 2025 Feb 11;25(1):570. doi: 10.1186/s12889-025-21757-w.
4
Correlation of cardiometabolic index and sarcopenia with cardiometabolic multimorbidity in middle-aged and older adult: a prospective study.中心血管代谢指数和肌肉减少症与中年和老年人中心血管代谢合并症的相关性:一项前瞻性研究。
Front Endocrinol (Lausanne). 2024 May 28;15:1387374. doi: 10.3389/fendo.2024.1387374. eCollection 2024.
5
Association of cognitive frailty and abdominal obesity with cardiometabolic multimorbidity among middle-aged and older adults: A longitudinal study.认知衰弱和腹型肥胖与中老年人心血管代谢性多重疾病的关系:一项纵向研究。
J Affect Disord. 2023 Nov 1;340:523-528. doi: 10.1016/j.jad.2023.08.067. Epub 2023 Aug 16.
6
Household air pollution, adherence to a healthy lifestyle, and risk of cardiometabolic multimorbidity: Results from the China health and retirement longitudinal study.家庭空气污染、遵循健康生活方式与心血管代谢性多病共病风险:来自中国健康与养老追踪调查的结果。
Sci Total Environ. 2023 Jan 10;855:158896. doi: 10.1016/j.scitotenv.2022.158896. Epub 2022 Sep 20.
7
Association of Visceral Adiposity Index and Handgrip Strength with Cardiometabolic Multimorbidity among Middle-Aged and Older Adults: Findings from Charls 2011-2020.内脏脂肪指数与握力与中老年人心血管代谢性多种疾病的相关性:来自 CHARLS 2011-2020 年的研究结果。
Nutrients. 2024 Jul 15;16(14):2277. doi: 10.3390/nu16142277.
8
National cohort study on cardiometabolic index and incident stroke in middle-aged and older adults in China.中国中老年人心血管代谢指数与新发中风的全国队列研究。
J Stroke Cerebrovasc Dis. 2025 May;34(5):108270. doi: 10.1016/j.jstrokecerebrovasdis.2025.108270. Epub 2025 Mar 3.
9
Assessment of six surrogate insulin resistance indexes for predicting cardiometabolic multimorbidity incidence in Chinese middle-aged and older populations: Insights from the China health and retirement longitudinal study.评估六种替代胰岛素抵抗指标在中国中年及以上人群中预测心血管代谢性多种疾病发病的价值:来自中国健康与养老追踪调查的见解。
Diabetes Metab Res Rev. 2024 Jan;40(1):e3764. doi: 10.1002/dmrr.3764.
10
Long-term dual-trajectories of TyG and LAP and their association with cardiometabolic multimorbidity in midlife: the CARDIA study.中年时期甘油三酯与葡萄糖比值(TyG)和脂质蓄积产物(LAP)的长期双重轨迹及其与心脏代谢多病共患的关联:CARDIA研究
Cardiovasc Diabetol. 2025 May 9;24(1):198. doi: 10.1186/s12933-025-02761-1.

引用本文的文献

1
The association between triglyceride glucose-waist height ratio index and cardiometabolic multimorbidity among Chinese middle-aged and older adults: a national prospective cohort study.甘油三酯葡萄糖-腰围身高比指数与中国中老年人心血管代谢多种合并症之间的关联:一项全国性前瞻性队列研究
Cardiovasc Diabetol. 2025 Sep 2;24(1):358. doi: 10.1186/s12933-025-02919-x.
2
Total cholesterol/high-density lipoprotein cholesterol-related indices as predictors of obstructive sleep apnea and cardiovascular mortality: A cross-sectional study.总胆固醇/高密度脂蛋白胆固醇相关指标作为阻塞性睡眠呼吸暂停和心血管疾病死亡率的预测指标:一项横断面研究。
Medicine (Baltimore). 2025 Jun 13;104(24):e42872. doi: 10.1097/MD.0000000000042872.
3

本文引用的文献

1
Obesity reshapes regulatory T cells in the visceral adipose tissue by disrupting cellular cholesterol homeostasis.肥胖通过破坏细胞胆固醇稳态重塑内脏脂肪组织中的调节性T细胞。
Sci Immunol. 2025 Jan 10;10(103):eadl4909. doi: 10.1126/sciimmunol.adl4909.
2
Adipokines: masterminds of metabolic inflammation.脂肪因子:代谢性炎症的幕后主使
Nat Rev Immunol. 2025 Apr;25(4):250-265. doi: 10.1038/s41577-024-01103-8. Epub 2024 Nov 7.
3
The impact of metabolic heterogeneity of obesity and transitions on cardiovascular disease incidence in Chinese middle-aged and elderly population: A nationwide prospective cohort study.
The joint effect of weight-adjusted waist index and physical activity on all-cause mortality in Chinese elderly patients with multimorbidity: A study based on the CLHLS from 2011 to 2018.
体重调整腰围指数与身体活动对中国老年多病患者全因死亡率的联合影响:基于2011年至2018年中国老年健康影响因素跟踪调查(CLHLS)的研究
PLoS One. 2025 Jun 9;20(6):e0325886. doi: 10.1371/journal.pone.0325886. eCollection 2025.
肥胖及代谢变化的异质性对中国中老年人群心血管疾病发病率的影响:一项全国性前瞻性队列研究
Diabetes Obes Metab. 2025 Feb;27(2):501-510. doi: 10.1111/dom.16040. Epub 2024 Nov 4.
4
Lipid profiling identifies modifiable signatures of cardiometabolic risk in children and adolescents with obesity.脂质分析可识别肥胖儿童和青少年心血管代谢风险的可改变特征。
Nat Med. 2025 Jan;31(1):294-305. doi: 10.1038/s41591-024-03279-x. Epub 2024 Sep 20.
5
Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women.炎症、胆固醇、脂蛋白(a)与女性30年心血管结局
N Engl J Med. 2024 Dec 5;391(22):2087-2097. doi: 10.1056/NEJMoa2405182. Epub 2024 Aug 31.
6
Association between triglyceride-glucose related indices and all-cause and cause-specific mortality in the general population: a cohort study.普通人群中甘油三酯-葡萄糖相关指标与全因死亡率和特定病因死亡率之间的关联:一项队列研究。
Cardiovasc Diabetol. 2024 Aug 7;23(1):286. doi: 10.1186/s12933-024-02390-0.
7
A new framework for the diagnosis, staging and management of obesity in adults.成人肥胖症诊断、分期及管理的新框架。
Nat Med. 2024 Sep;30(9):2395-2399. doi: 10.1038/s41591-024-03095-3.
8
Association of noise exposure with lipid metabolism among Chinese adults: mediation role of obesity indices.中国成年人噪声暴露与脂质代谢的关联:肥胖指数的中介作用
J Endocrinol Invest. 2025 Jan;48(1):245-255. doi: 10.1007/s40618-024-02420-4. Epub 2024 Jun 23.
9
Association between atherogenic index of plasma and new-onset stroke in individuals with different glucose metabolism status: insights from CHARLS.载脂蛋白相关指数与不同糖代谢状态个体新发脑卒中的相关性:来自 CHARLS 的见解。
Cardiovasc Diabetol. 2024 Jun 21;23(1):215. doi: 10.1186/s12933-024-02314-y.
10
Joint association of TyG index and high sensitivity C-reactive protein with cardiovascular disease: a national cohort study.糖化血红蛋白与超敏 C 反应蛋白联合与心血管疾病的相关性:一项全国性队列研究。
Cardiovasc Diabetol. 2024 May 7;23(1):156. doi: 10.1186/s12933-024-02244-9.